Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII complex in progressive systemic sclerosis.

L Pagano, R Marra, S Paoletti

    Clinical and Experimental Rheumatology
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Exploring the short linear motif-mediated protein-protein interactions of CrkL through ProP-PD.

    Biochemical and biophysical research communications·2024
    Same author

    Liposomal amphotericin B-the present.

    The Journal of antimicrobial chemotherapy·2022
    Same author

    SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report.

    Journal of investigational allergology & clinical immunology·2022
    Same author

    Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes.

    Journal of endocrinological investigation·2021
    Same author

    Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium.

    Blood cancer journal·2020
    Same author

    Role of Stenotrophomonas maltophilia isolation in patients with non-CF bronchiectasis.

    QJM : monthly journal of the Association of Physicians·2020
    Same journal

    The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

    Clinical and experimental rheumatology·2026
    Same journal

    Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

    Clinical and experimental rheumatology·2026
    Same journal

    Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

    Clinical and experimental rheumatology·2026
    Same journal

    Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

    Clinical and experimental rheumatology·2026
    Same journal

    Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

    Clinical and experimental rheumatology·2026
    Same journal

    Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

    Clinical and experimental rheumatology·2026
    See all related articles

    Progressive Systemic Sclerosis (PSS) patients show elevated Factor VIII complex activities compared to healthy individuals. While Factor VIII-related Antigen and Ristocetin Cofactor increased similarly, Coagulant activity showed a proportionally smaller rise.

    Area of Science:

    • Hematology
    • Rheumatology
    • Immunology

    Background:

    • Progressive Systemic Sclerosis (PSS) is an autoimmune disorder affecting connective tissues.
    • The role of coagulation factors in PSS pathogenesis requires further elucidation.
    • Factor VIII complex activities have not been extensively studied in PSS subtypes.

    Purpose of the Study:

    • To investigate Factor VIII complex activities in patients with Progressive Systemic Sclerosis.
    • To compare Factor VIII-related activities between acrosclerosis and diffuse sclerosis subtypes.
    • To explore potential pathogenetic mechanisms underlying observed changes in Factor VIII.

    Main Methods:

    • Assessed Factor VIII coagulant activity (F. VIII:C), Factor VIII-related Antigen (F. VIIIR:Ag), and Factor VIII Ristocetin Cofactor (F. VIIIR:Co).

    Related Experiment Videos

  • Studied 23 patients with PSS, categorized into acrosclerosis and diffuse sclerosis groups.
  • Compared patient data against normal subject values.

    • Main Results:

    • All investigated Factor VIII-related activities were significantly higher in PSS patients than in normal subjects.
    • No significant differences in F. VIIIR:Ag, F. VIIIR:Co, or F. VIII:C were observed between acrosclerosis and diffuse sclerosis groups.
    • F. VIII:C demonstrated a proportionally smaller increase compared to F. VIIIR:Ag and F. VIIIR:Co in both PSS patient groups.

    Conclusions:

    • Elevated Factor VIII complex activities are characteristic of Progressive Systemic Sclerosis.
    • The distinct pattern of increase suggests potential alterations in Factor VIII regulation or clearance in PSS.
    • Further research is warranted to understand the implications of these findings for PSS pathogenesis and potential therapeutic targets.